In addition, Ellipses Pharma tells
Pharmafocus about next generation SRIs and why the clinical trial landscape should be improved (
page 14), Phesi considers patient enrolment and retention in oncology clinical trials (
page 16) and Gilead Sciences assesses the current standard of care for blood cancer patients and how this could develop going forward (
page 18). Also in this issue, Charac weighs up the pros and cons of the new NHS’ Pharmacy First scheme (
page 20), and Cognitant Group tells us how patient support programmes should be streamlined using a simple five-step approach (
page 22).